Wound Debridement Market Expected to Reach $5.67 Billion by 2030

According to a new report published by Allied Market Research, titled, “Wound Debridement Market by Product, Wound Type, Method, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,”

The wound debridement market size was valued at $4.13 billion in 2020, and is projected to reach $5.67 billion by 2030, registering a CAGR of 3.2% from 2021 to 2030.

Wound debridement contributes to the cleaning process by removing the thickened skin or callus, infected, and nonviable, necrotic, or dead tissue. It is particularly useful in the treatment of burns, trauma, and surgical wounds. Furthermore, it is also useful in treating chronic wounds such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, and arterial ulcers. These products are generally used to absorb exudate, seize bleeding, close the open trauma & surgical wounds, and dry the wound to help it heal faster.

The major factor that boosts the growth of the wound debridement market include increase in incidence of chronic wounds, such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, arterial ulcers, and acute wound, including burn and trauma. Furthermore, increase in surgical procedure around the globe and the use of wound debridement products in a variety of surgeries to treat surgical wounds and trauma wounds are driving the market growth. Moreover, rise in aging population around the globe further drives the growth of the wound debridement market due to rise in number of cases of diabetic foot ulcers among the elderly. However, high cost of advanced wound care products limits the market growth of wound debridement during the forecast period. In contrast, growth potential in emerging economies is expected to provide lucrative opportunities for wound debridement product adoption.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has a negative effect on wound debridement products. The ability to practice wound healing under normal conditions is restricted during the COVID-19 pandemic, according to an article published in the U.S. National Library of Medicine National Institutes of Health. Moreover, according to an article published in Wound Research, several hospitals have closed their wound centers as they misclassified the facility as non-essential or as they restricted visitors and outpatients from accessing the hospital premises.

The wound debridement market is segmented on the basis of product, wound type, method, end user, and region. On the basis of product, the market is categorized into gels, ointments & creams, surgical devices, debridement pads, and others. The ointments & creams segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. Rise in number of cases of acute wounds, including burn, trauma, surgical wounds, and chronic wounds, such as diabetic foot ulcer and pressure ulcer, drives the growth of this segment as ointments & creams are majorly used as a primary dressing for these wounds.

On the basis of wound type, the market is divided into diabetic foot ulcers, pressure ulcers, surgical & trauma wounds, burns, and others. The diabetic foot ulcers segment is expected to account for the largest revenue during forecast period, owing to rise in cases of trauma across the globe. The surgical & trauma wounds segment is anticipated to witness the fastest growth rate during the forecast period, owing to increase in cases of burn injuries.

On the basis of method, the market is classified into enzymatic debridement, surgical debridement, mechanical debridement, and others. Others include autolytic & biological. The surgical debridement segment is expected to account for the largest revenue during the forecast period, owing to rise in geriatric population and surgical wounds and trauma wounds across the globe. The enzymatic debridement segment is anticipated to witness the fastest growth rate during the forecast period, owing to increase in cases of burn injuries.

By end user, the market is segmented into hospitals, clinics, and others. Others include long-term care facilities and home healthcare. The hospitals segment accounted for maximum market revenue in 2020 and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in cases of diabetic foot ulcers, pressure ulcers and surgical & trauma wounds as well as surge in surgical wound cases due to rise in number of surgeries performed in hospitals.

North America accounted for the largest share of the wound debridement market in 2020 and is expected to remain dominant during the forecast period. This is attributed to increase in sports injuries & road accidents and rise in prevalence of chronic wound in the region, thus escalating the demand for wound debridement products for road accidents & sports injuries. In addition, improvement in healthcare infrastructure is anticipated to boost the wound debridement market during the forecast period. The Asia-Pacific wound debridement market is expected to register significant growth rate during the forecast period, owing to number of factors, including increase in cases of burns, trauma as well as constantly expanding healthcare infrastructure, presence of untapped resources, economic development, and increase in number of cases of chronic diseases, especially diabetes, which are projected to drive the growth of the wound debridement market in emerging countries in Asia-Pacific.

Key Findings Of The Study

• By product, the ointments & creams segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By wound type, the diabetic foot ulcers segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By method, the surgical debridement segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By end user, the hospital segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By region, North America to experience market growth at the highest rate, registering a CAGR of 3.6% during the forecast period.